Table 2.
Baseline* characteristics | Number | Percent |
---|---|---|
Baseline functional status | ||
Working | 1646 | 80.8 |
Ambulatory | 276 | 13.6 |
Bedridden | 114 | 5.6 |
WHO stage at ART initiation | ||
WHO stage I | 422 | 20.7 |
WHO stage II | 304 | 14.9 |
WHO stage III | 1196 | 58.7 |
WHO stage IV | 114 | 5.6 |
Baseline CD4 count | ||
≤200 | 1705 | 85.5 |
201–300 | 252 | 12.6 |
>300 | 37 | 1.9 |
Median CD4 (mm3) (IQR) | 121.0 (169.0–64.0) mm3 | |
Baseline HgB level | ||
Anemic | 383 | 43.3 |
Nonanemic | 501 | 56.7 |
Median HgB (mg/dL) (IQR) | 13.6 mg/dL (11 mg/dL–14.6 mg/dL) | |
Patient screened for TB | ||
Yes | 1940 | 95.3 |
No | 96 | 4.7 |
TB coinfection at initiation of ART | ||
Positive | 285 | 14.7 |
Negative | 1655 | 85.3 |
Baseline BMI | ||
<18.5 | 11 | 1.3 |
18.5–24.9 | 756 | 88.6 |
≥25.0 | 86 | 10.1 |
Median weight (Kg) (IQR) | 50.0 Kg (57 Kg–45 Kg) |
*Baseline indicates measurements at initiation of ART.